Compare Malacca Trust Wuwungan Insurance Tbk. (MTWI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Malacca Trust Wuwungan Insurance Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Malacca Trust Wuwungan Insurance Tbk. trades at Rp274 (market cap 795.46B, 63.5K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Malacca Trust Wuwungan Insurance Tbk. is far larger — about 7.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MTWI | SCPI | |
|---|---|---|
Market Cap | 795.46B | 104.4B |
Volume | 63.5K | — |
Lot | 635 | — |
Turnover | 17.37M | — |
Average Price | 273.54 | — |
Value | 17.37M | — |
Indicative Equilibrium Price | 274 | — |
Indicative Equilibrium Volume | 39 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Malacca Trust Wuwungan Insurance Tbk.
PT Malacca Trust Wuwungan Insurance (the Company) formerly known as PT Asuransi wuwungan, was established based on Notarial Deed No. 76 dated December 15, 1952, which was amended based on Deed No. 133 dated January 21, 1953 of Raden Mas Soerojo, S.H., Notary in Jakarta.Since 2011, Malacca Trust Limited, a Singapore-based holding company, through its subsidiaries Batavia Prosperindo International and Batavia Prosperindo Finance, has successfully become a majority shareholder of PT Malacca Trust Wuwungan Insurance. This completes the entire Malacca Trust Limited business in the financial industry where previously it has owned asset management, securities & multi finance company based in Indonesia.
Read more on MTWI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
